论文部分内容阅读
目的:观察替米沙坦治疗糖尿病肾病(DN)尿微量白蛋白的疗效。方法:选择52例早期DN患者。随机分为治疗组和对照组,对照组给予胰岛素治疗,治疗组在对照组治疗基础上加用替米沙坦。两组均治疗2个月后检测尿微量白蛋白排泌率(UAER)。结果:两组治疗后UAER均有下降,而治疗组治疗前后差异有统计学意义(P<0.05)。治疗后治疗组和对照组比较差异有统计学意义(P<0.05)。结论:替米沙坦可减少糖尿病肾病UAER。
Objective: To observe the efficacy of telmisartan in the treatment of diabetic nephropathy (DN) urinary albumin. Methods: 52 patients with early DN were selected. Randomly divided into treatment group and control group, the control group given insulin treatment, the treatment group in the control group based on the treatment plus telmisartan. Urinary albumin excretion rate (UAER) was measured in both groups after 2 months of treatment. Results: UAER decreased after treatment in both groups, but the difference between the two groups was statistically significant (P <0.05). The difference between the treatment group and the control group after treatment was statistically significant (P <0.05). Conclusion: Telmisartan can reduce diabetic nephropathy UAER.